Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (AHCO) delivers essential home medical equipment and healthcare-at-home services, empowering patients through respiratory care, mobility solutions, and chronic condition management. This page provides centralized access to all official company announcements and market-relevant developments.
Investors and healthcare professionals will find timely updates on earnings reports, regulatory milestones, product launches, and strategic partnerships. Our curated collection includes press releases on sleep therapy innovations, respiratory equipment advancements, and operational expansions across AHCO's nationwide network.
Key areas covered include quarterly financial results, clinical service enhancements, Medicare/Medicaid compliance updates, and technology integrations in home healthcare. All content is sourced directly from AdaptHealth's communications to ensure accuracy and relevance for stakeholders.
Bookmark this page for streamlined access to AHCO's latest business developments. Check regularly for updates impacting the home healthcare sector and AdaptHealth's position within this critical industry.
AdaptHealth Corp. (NASDAQ: AHCO) announced the grant of restricted stock units (RSUs) to Suzanne Foster, the newly appointed CEO, as an inducement under Nasdaq Listing Rule 5635(c)(4). The grant, approved by the Compensation Committee on May 11, 2024, covers 553,251 shares of common stock at target performance levels. The RSUs vest in three tranches: 229,740 shares over three years starting May 20, 2025, 93,771 shares over two years starting the same date, and the remaining shares based on the Total Shareholder Return (TSR) over a three-year period. The vesting depends on Ms. Foster's continued service with AdaptHealth. The company provides home medical equipment and services, reaching 4.1 million patients annually across 670 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in the 2024 Leerink Partners Healthcare Crossroads Conference in Austin on May 29, 2024, with a fireside chat at 3:00 PM CT. AdaptHealth is a national provider of patient-centered healthcare-at-home solutions, including home medical equipment, supplies, and related services. Their services cater to patients with chronic conditions, offering sleep therapy equipment, diabetes treatment devices, and other home medical equipment. The company reaches approximately 4.1 million patients annually across all 50 states through 680 locations in 47 states. A webcast link for the event will be available on the company's website under 'Investor Relations'.
AdaptHealth Corp. will participate in the BofA Securities 2024 Health Care Conference, with key executives engaging in a fireside chat. The Company offers patient-centered healthcare-at-home solutions, catering to over 4.1 million patients annually in all 50 states. AdaptHealth provides a wide range of medical products and services, including sleep therapy equipment, diabetes treatment supplies, HME devices, oxygen therapy, and other related services.
AdaptHealth Corp. announced financial results for the first quarter ended March 31, 2024. Net revenue increased by 6.4% to $792.5 million. However, net loss was $2.1 million compared to net income of $15.7 million in the same period last year. Adjusted EBITDA increased by 18.3% to $158.5 million. Cash flow from operations decreased to $49.0 million, and Free Cash Flow decreased to $(38.9) million due to delayed payments from the Change Healthcare data breach.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
